Aspire Private Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13
| Closed | -$8.07K | – | 583 |
|
|
2024
Q3 | $8.07K | Hold |
13
| – | – | ﹤0.01% | 413 |
|
|
2024
Q2 | $7.21K | Hold |
13
| – | – | ﹤0.01% | 426 |
|
|
2024
Q1 | $7.57K | Hold |
13
| – | – | ﹤0.01% | 434 |
|
|
2023
Q4 | $6.92K | Sell |
13
-24
| -65% | -$12.8K | ﹤0.01% | 435 |
|
|
2023
Q3 | $18.7K | Buy |
37
+14
| +61% | +$7.09K | 0.01% | 320 |
|
|
2023
Q2 | $12K | Buy |
23
+10
| +77% | +$5.22K | ﹤0.01% | 358 |
|
|
2023
Q1 | $7.5K | Hold |
13
| – | – | ﹤0.01% | 400 |
|
|
2022
Q4 | $7.17K | Sell |
13
-9
| -41% | -$4.96K | ﹤0.01% | 392 |
|
|
2022
Q3 | $11K | Hold |
22
| – | – | ﹤0.01% | 338 |
|
|
2022
Q2 | $12K | Hold |
22
| – | – | ﹤0.01% | 332 |
|
|
2022
Q1 | $13K | Sell |
22
-10
| -31% | -$5.91K | ﹤0.01% | 326 |
|
|
2021
Q4 | $21K | Buy |
32
+9
| +39% | +$5.91K | 0.01% | 283 |
|
|
2021
Q3 | $13K | Hold |
23
| – | – | ﹤0.01% | 295 |
|
|
2021
Q2 | $12K | Buy |
23
+10
| +77% | +$5.22K | ﹤0.01% | 312 |
|
|
2021
Q1 | $6K | Sell |
13
-331
| -96% | -$153K | ﹤0.01% | 371 |
|
|
2020
Q4 | $160K | Buy |
344
+9
| +3% | +$4.19K | 0.06% | 137 |
|
|
2020
Q3 | $148K | Buy |
335
+43
| +15% | +$19K | 0.06% | 126 |
|
|
2020
Q2 | $106K | Buy |
292
+23
| +9% | +$8.35K | 0.05% | 129 |
|
|
2020
Q1 | $76K | Sell |
269
-128
| -32% | -$36.2K | 0.04% | 136 |
|
|
2019
Q4 | $129K | Buy |
397
+6
| +2% | +$1.95K | 0.06% | 138 |
|
|
2019
Q3 | $114K | Buy |
391
+32
| +9% | +$9.33K | 0.05% | 142 |
|
|
2019
Q2 | $105K | Buy |
359
+351
| +4,388% | +$103K | 0.05% | 148 |
|
|
2019
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 457 |
|
|
2018
Q4 | $2K | Buy |
+8
| New | +$2K | ﹤0.01% | 430 |
|